France · Delayed Price · Currency is EUR Exosens Statistics
Total Valuation
Exosens has a market cap or net worth of EUR 2.91 billion. The enterprise value is 3.11 billion.
| Market Cap | 2.91B |
| Enterprise Value | 3.11B |
Important Dates
The last earnings date was Tuesday, July 28, 2026.
| Earnings Date | Jul 28, 2026 |
| Ex-Dividend Date | May 27, 2026 |
Share Statistics
Exosens has 50.91 million shares outstanding. The number of shares has increased by 9.27% in one year.
| Current Share Class | 50.91M |
| Shares Outstanding | 50.91M |
| Shares Change (YoY) | +9.27% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.58% |
| Owned by Institutions (%) | 33.33% |
| Float | 32.83M |
Valuation Ratios
The trailing PE ratio is 51.86 and the forward PE ratio is 27.50. Exosens's PEG ratio is 1.37.
| PE Ratio | 51.86 |
| Forward PE | 27.50 |
| PS Ratio | 5.80 |
| PB Ratio | 6.46 |
| P/TBV Ratio | 28.04 |
| P/FCF Ratio | 50.18 |
| P/OCF Ratio | 24.30 |
| PEG Ratio | 1.37 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 20.49, with an EV/FCF ratio of 53.63.
| EV / Earnings | 103.24 |
| EV / Sales | 6.20 |
| EV / EBITDA | 20.49 |
| EV / EBIT | 35.96 |
| EV / FCF | 53.63 |
Financial Position
The company has a current ratio of 2.35, with a Debt / Equity ratio of 0.60.
| Current Ratio | 2.35 |
| Quick Ratio | 1.32 |
| Debt / Equity | 0.60 |
| Debt / EBITDA | 1.77 |
| Debt / FCF | 4.64 |
| Interest Coverage | 7.34 |
Financial Efficiency
Return on equity (ROE) is 12.70% and return on invested capital (ROIC) is 10.31%.
| Return on Equity (ROE) | 12.70% |
| Return on Assets (ROA) | 6.19% |
| Return on Invested Capital (ROIC) | 10.31% |
| Return on Capital Employed (ROCE) | 11.31% |
| Weighted Average Cost of Capital (WACC) | 8.48% |
| Revenue Per Employee | 250,888 |
| Profits Per Employee | 15,073 |
| Employee Count | 2,000 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 1.75 |
Taxes
In the past 12 months, Exosens has paid 16.77 million in taxes.
| Income Tax | 16.77M |
| Effective Tax Rate | 23.07% |
Stock Price Statistics
The stock price has increased by +42.15% in the last 52 weeks. The beta is 0.86, so Exosens's price volatility has been lower than the market average.
| Beta (5Y) | 0.86 |
| 52-Week Price Change | +42.15% |
| 50-Day Moving Average | 59.70 |
| 200-Day Moving Average | 56.62 |
| Relative Strength Index (RSI) | 50.03 |
| Average Volume (20 Days) | 87,273 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Exosens had revenue of EUR 501.78 million and earned 30.15 million in profits. Earnings per share was 0.59.
| Revenue | 501.78M |
| Gross Profit | 301.70M |
| Operating Income | 87.29M |
| Pretax Income | 72.69M |
| Net Income | 30.15M |
| EBITDA | 151.90M |
| EBIT | 86.54M |
| Earnings Per Share (EPS) | 0.59 |
Balance Sheet
The company has 69.23 million in cash and 269.47 million in debt, with a net cash position of -200.24 million or -3.93 per share.
| Cash & Cash Equivalents | 69.23M |
| Total Debt | 269.47M |
| Net Cash | -200.24M |
| Net Cash Per Share | -3.93 |
| Equity (Book Value) | 450.88M |
| Book Value Per Share | 8.86 |
| Working Capital | 175.79M |
Cash Flow
In the last 12 months, operating cash flow was 119.86 million and capital expenditures -61.82 million, giving a free cash flow of 58.04 million.
| Operating Cash Flow | 119.86M |
| Capital Expenditures | -61.82M |
| Depreciation & Amortization | 17.60M |
| Net Borrowing | -2.81M |
| Free Cash Flow | 58.04M |
| FCF Per Share | 1.14 |
Margins
Gross margin is 60.13%, with operating and profit margins of 17.40% and 6.01%.
| Gross Margin | 60.13% |
| Operating Margin | 17.40% |
| Pretax Margin | 14.49% |
| Profit Margin | 6.01% |
| EBITDA Margin | 30.27% |
| EBIT Margin | 17.25% |
| FCF Margin | 11.57% |
Dividends & Yields
This stock pays an annual dividend of 0.30, which amounts to a dividend yield of 0.52%.
| Dividend Per Share | 0.30 |
| Dividend Yield | 0.52% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 50.43% |
| Buyback Yield | -9.27% |
| Shareholder Yield | -8.75% |
| Earnings Yield | 1.04% |
| FCF Yield | 1.99% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Exosens is 67.03, which is 14.68% higher than the current price. The consensus rating is "Buy".
| Price Target | 67.03 |
| Price Target Difference | 14.68% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (3Y) | 14.08% |
| EPS Growth Forecast (3Y) | 20.06% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Exosens has an Altman Z-Score of 4.81 and a Piotroski F-Score of 6.
| Altman Z-Score | 4.81 |
| Piotroski F-Score | 6 |